Ropes & Gray has advised Eli Lilly and Company, and Cooley has advised Adverum Biotechnologies, Inc. Eli Lilly and Company has entered into a definitive agreement...
Eli Lilly Announces Acquisition of Adverum Biotechnologies for Up to $1.3 Billion
Sagard Healthcare Partners’ $250 Million Non-Dilutive Financings to Nuvation Bio
Cooley represented Nuvation Bio in the transaction, and Sidley Austin represented Sagard Healthcare Partners. Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the...
Thirty Madison’s $32.3 Million Asset Purchase from The Pill Club
Cooley advised Thirty Madison on the deal. Thirty Madison announced that it will ensure continued care for over a hundred thousand patients after strategically acquiring assets,...
Amgen’s Acquisition of Horizon Therapeutics
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
Blueprint Medicines Corporation’s Financing Collaborations with Sixth Street and Royalty Pharma
Goodwin Procter advised Blueprint Medicines Corporation on the deal while Cooley represented Sixth Street. Blueprint Medicines Corporation (NASDAQ: BPMC) announced its strategic financing collaborations with Sixth...
Alpargatas’ $475 Million Series B Investment in Rothy’s
Mayer Brown represented Alpargatas S.A. in the transaction while Cooley advised Rothy. Alpargatas S.A., a Brazil-based, global footwear company creator of the famous flip flop “Havaianas,”...
Dotdash’s Acquisition of Meredith Corporation’s National Media Group
Wachtell, Lipton, Rosen & Katz represented IAC, while Cooley represented Meredith in the transaction. IAC (NASDAQ: IAC) and Meredith Corporation (NYSE: MDP), a leading media company...